Sharjah Charity International spent more than Dh60.8 million in 2014 in support of the poor around the world.
Director of the Department of Projects at Sharjah Charity International, Mohammed Hamdan Al Zari, said that more than Dh37.2 million of the total funds spent last year were used for building 1,257 mosques in a large number of Arab and other countries in Asia and Africa.
Contents of this issue:
27 March 2015, vol. 90, 13 (pp. 121-132)
121 Reducing mortality from emerging diseases
123 Meningococcal disease control in countries of the African meningitis belt, 2014
27 mars 2015, vol. 90, 13 (pp. 121-132)
121 Réduire la mortalité des maladies émergentes
123 Lutte contre la méningite à méningocoques dans les pays de la ceinture africaine de la méningite, 2014
Washington, United States | | Friday 3/27/2015 - 08:49 GMT
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
The results confirm two clinical trials, each with some 20 people, that were carried out earlier in the United States.
The current, unprecedented epidemic of the disease has killed more than 10,000 people since it first emerged in early 2014 in west Africa, mainly in Liberia, Sierra Leone and Guinea.
Veuillez trouver ci-joint le rapport de surveillance syndromique du Pacifique pour la semaine 12 qui s’est achevée le 22 mars 2015.
Les alertes suivantes ont été signalées:
Diarrhée: Polynésie française, Pitcairn ;
Syndrome grippal: Polynésie française, Pitcairn, Wallis & Futuna ;
Fièvre prolongée: Iles Salomon.
Autres mises à jour:
Cyclone tropical Pam
Washington, United States | | Thursday 3/26/2015 - 21:56 GMT
The Ebola virus is not mutating as quickly as scientists had feared, which is good news for treating the disease and preventing its spread, a study showed Thursday.
Previous research based on limited data had suggested that Ebola was mutating twice as quickly as in the past, researchers said in the journal Science.
The following syndromes have been flagged:
Diarrhoea: French Polynesia, Pitcairn Islands
Influenza-like illness: French Polynesia, Pitcairn Islands, Wallis & Futuna
Prolonged Fever: Solomon Islands
Tropical Cyclone Pam
A challenge stands before us: ensuring immunisation of the world’s poorest children.If we, as global citizens can meet it, we will help protect the lives of millions in places too poor to afford vaccines.
Despite remarkable progress made by Gavi, the Vaccine Alliance in helping to immunise half a billion children since 2000, nearly one-in-five children are still missing out, such that every year, 1.5 million still die from vaccine-preventable diseases.
Nairobi, 24 mars 2015 (IRIN) - Le Liberia n'a enregistré qu'un nouveau cas d'Ebola au cours des trois dernières semaines, mais il est encore trop tôt pour savoir si le virus a presque été éradiqué – les frontières du pays sont poreuses et ses voisins n'ont pas réussi à maîtriser leurs épidémies.
Lack of political commitment will jeopardize momentum for stronger TB action across the region
Geneva – 24 March 2015 – One week ahead of the first-ever Eastern Partnership Ministerial Conference on Tuberculosis and Multidrug Resistant Tuberculosis in Riga, Latvia, on 30/31 March, Médecins Sans Frontières (MSF) expressed great concern over news that European Health Commissioner Andriukaitis is not attending the meeting and that fewer than a quarter of invited countries are sending Health Ministers or Deputy Health Ministers to the meeting.
Britain to remain at the forefront of the fight against TB by funding the development of a simpler, safer and more affordable treatment.
Britain is funding a global clinical trial of new treatments to beat drug-resistant strains of tuberculosis that threaten to reverse decades of progress in fighting the disease, International Development Secretary Justine Greening said today.
Justine Greening said:
Snapshot 18-24 March 2015
Syria: The Government carried out over 10,000 airstrikes between October and March, dropping more than 5,300 barrel bombs and killing almost 2,200 civilians. A chlorine attack on 16 March in Idleb killed six people.
Switzerland - March 24 marks World TB Day with the theme “Reach the 3 Million: Reach, Treat, Cure Everyone.”
Tuberculosis is one of the world’s top health challenges with 9 million new cases and the deaths of nearly 1.5 million people each year. Approximately one third of these 9 million cases of TB are missed by the health system. Among those missed are those most vulnerable to TB: people living with HIV/AIDS, migrants, refugees and internally displaced persons, miners, ethnic minorities and indigenous populations.
World TB Day 2015
Tuberculosis remains one of the world’s deadliest communicable diseases. In 2013, an estimated nine million people developed tuberculosis (TB) and 1.5 million died from the disease, 360,000 of whom were HIV-positive. TB is slowly declining each year and it is estimated that 37 million lives were saved between 2000 and 2013 through effective diagnosis and treatment.
World Tuberculosis Day reminds us all of the important work under way to eradicate this highly infectious and sometimes fatal disease, but also that more needs to be done to save lives across the Pacific and globally.
“We’ve achieved significant progress in the detection and treatment of tuberculosis cases in the Pacific region in recent years, but a renewed effort is essential to ‘reach, treat and cure everyone’,” according to a Tuberculosis Epidemiologist at the Secretariat of the Pacific Community (SPC), Jojo Merilles.
Minister for Foreign Affairs
The Hon Julie Bishop MP
Today I launch innovationXchange – an Australian Government initiative to revolutionise the delivery and effectiveness of Australia’s aid program.
The $140 million project, the next phase of the Australian Government’s new aid paradigm, will mainstream innovation throughout the Department of Foreign Affairs and Trade.
The buzz started well before the first new TB drug in half a century was approved for use on the last day of 2012: two forthcoming new TB medicines would radically improve cure and survival rates for drug-resistant tuberculosis (DR-TB), displacing the toxic and grueling multi-year treatments that, even with only a 50% chance of cure, were the only options available.
As an organisation struggling to treat people with DR-TB in more than 20 countries with today’s inadequate tools, MSF shared this excitement.